or
forgot password

    • cancer clinical trials in springfield, IL

    • S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumor
    Regional Cancer Center at Memorial Medical Center
    Springfield, Illinois 62781-0001
    Sarcoma
    Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Cancer of the Vulva
    Regional Cancer Center at Memorial Medical Center
    Springfield, Illinois 62781-0001
    Vulvar Cancer
    Gemcitabine and Vinorelbine in Treating Young Patients With Recurrent or Refractory Hodgkin's Lymphoma
    Southern Illinois University School of Medicine
    Springfield, Illinois 62794-9658
    Lymphoma
    Oxaliplatin in Treating Patients With Persistent or Recurrent Endometrial Cancer
    CCOP - Central Illinois
    Springfield, Illinois 62526
    Endometrial Cancer
    Study Evaluating CMC-544 In B-Cell Non-Hodgkin's Lymphoma
    Pfizer Investigational Site
    Springfield, Illinois 62701-1014
    Lymphoma, B-Cell
    A Study To Assess The Safety And Efficacy Of SU11248 In Patients With Gastrointestinal Stromal Tumor(GIST)
    Pfizer Investigational Site
    Springfield, Illinois 62701-1014
    Gastrointestinal Stromal Tumor
    Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma
    Southern Illinois University
    Springfield, Illinois 62702
    Adult Rhabdomyosarcoma, Embryonal Childhood Rhabdomyosarcoma, Embryonal-botryoid Childhood Rhabdomyosarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma
    S0205 Gemcitabine w/ or w/o Cetuximab as First-Line Therapy in Locally Advanced Pancreas Cancer
    Regional Cancer Center at Memorial Medical Center
    Springfield, Illinois 62781-0001
    Pancreatic Cancer
    Bortezomib in Treating Patients With Newly Diagnosed High-Risk Stage III Multiple Myeloma
    CCOP - Central Illinois
    Springfield, Illinois 62526
    Multiple Myeloma, Plasma Cell Neoplasm
    AG-013736 In Combination With Docetaxel Versus Docetaxel Alone For Patients With Metastatic Breast Cancer
    Pfizer Investigational Site
    Springfield, Illinois 62701-1014
    Breast Neoplasms
    Proteomic Profiling in Diagnosing Non-Small Cell Lung Cancer in Patients Who Are Undergoing Lung Resection for Suspicious Stage I Lung Lesions
    Southern Illinois University School of Medicine

    Trial Locations
    Southern Illinois University School of Medicine
    Regional Cancer Center at Memorial Medical Center
    Cancer Institute at St. John's Hospital
    Lung Cancer
    A Study of SU11248 In Patients With Metastatic Breast Cancer Who Have Failed Selected Other Therapies.
    Pfizer Investigational Site
    Springfield, Illinois 62701-1014
    Breast Neoplasms
    Amifostine in Treating Peripheral Neuropathy Caused by Paclitaxel in Patients With Solid Tumors
    CCOP - Central Illinois
    Springfield, Illinois 62526
    Breast Cancer, Lung Cancer, Neurotoxicity, Ovarian Cancer, Prostate Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    Thalidomide and Procarbazine in Treating Patients With Recurrent or Progressive Malignant Glioma
    CCOP - Central Illinois
    Springfield, Illinois 62526
    Brain and Central Nervous System Tumors
    hu14.18-Interleukin-2 Fusion Protein in Treating Young Patients With Recurrent or Refractory Neuroblastoma
    Southern Illinois University School of Medicine
    Springfield, Illinois 62794-9658
    Neuroblastoma
    SU011248 Versus Interferon-Alfa As First-Line Systemic Therapy For Patients With Metastatic Renal Cell Carcinoma
    Pfizer Investigational Site
    Springfield, Illinois 62701-1014
    Carcinoma, Renal Cell
    S0217, Adjuvant Cisplatin and Docetaxel After Complete Resection Stage III or IV Head and Neck Cancer
    Regional Cancer Center at Memorial Medical Center
    Springfield, Illinois 62781-0001
    Head and Neck Cancer
    Computed Tomographic Colonography in Screening Healthy Participants for Colorectal Cancer
    Clinical Radiologists, S.C. at Memorial Medical Center
    Springfield, Illinois 62781
    Colorectal Cancer
    Docetaxel in Treating Patients With Recurrent or Persistent Endometrial Carcinoma (Cancer)
    CCOP - Central Illinois
    Springfield, Illinois 62526
    Endometrial Cancer
    Non-small Cell Lung Cancer Study US75 (Z-PACT)
    Springfield Clinic, LLP
    Springfield, Illinois 62703
    Non Small Cell Lung Carcinoma
    Cetuximab and Carboplatin in Treating Patients With Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
    CCOP - Central Illinois
    Springfield, Illinois 62526
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    S0356 Oxaliplatin, 5-FU, Radiation Therapy (RT), Surgery for Pts With Stage II or III Cancer of Esophagus or Gastroesophageal (GE) Junction
    Regional Cancer Center at Memorial Medical Center
    Springfield, Illinois 62781-0001
    Esophageal Cancer
    SU011248 In The Treatment Of Patients With Bevacizumab (Avastin)-Refractory Metastatic Renal Cell Carcinoma
    Pfizer Investigational Site
    Springfield, Illinois 62701-1014
    Carcinoma, Renal Cell
    S0229, Pulmonary Rehabilitation Education w/wo Exercise Training in Improving Physical Function in Patients Who Are Undergoing Chemo & RT for Locally Advanced Lung Cancer
    Regional Cancer Center at Memorial Medical Center
    Springfield, Illinois 62781-0001
    Lung Cancer, Pulmonary Complications
    A Treatment Protocol for Patients With Gastrointestinal Stromal Tumor (GIST) Who May Derive Benefit From Treatment With SU011248
    Pfizer Investigational Site
    Springfield, Illinois 62701-1014
    Gastrointestinal Neoplasm
    Study of the Anti-angiogenesis Agent AG-013736 in Patients With Metastatic Thyroid Cancer
    Pfizer Investigational Site
    Springfield, Illinois 62701-1014
    Thyroid Neoplasms
    Anti-angiogenesis Agent AG-013736 in Patients With Advanced Non-Small Cell Lung Cancer
    Pfizer Investigational Site
    Springfield, Illinois 62701-1014
    Lung Neoplasms, Carcinoma, Non-small Cell Lung
    S0415 Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
    Regional Cancer Center at Memorial Medical Center
    Springfield, Illinois 62781-0001
    Esophageal Cancer
    Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer
    CCOP - Central Illinois
    Springfield, Illinois 62526
    Breast Cancer, Fatigue
    Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas
    Southern Illinois University School of Medicine
    Springfield, Illinois 62794-9658
    Brain and Central Nervous System Tumors
    Pemetrexed Plus Gemcitabine or Carboplatin for Patients With Advanced Malignant Pleural Mesothelioma
    Regional Cancer Center at Memorial Medical Center
    Springfield, Illinois 62781-0001
    Mesothelioma
    Trial Of Irinotecan In Combination With Three Methods Of Administration Of Fluoropyrimidine.
    Pfizer Investigational Site
    Springfield, Illinois 62701-1014
    Colorectal Neoplasms
    Cetuximab in Treating Patients With Recurrent or Stage IIIB or Stage IV Lung Cancer
    Regional Cancer Center at Memorial Medical Center
    Springfield, Illinois 62781-0001
    Lung Cancer
    Bortezomib With or Without Irinotecan in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
    Regional Cancer Center at Memorial Medical Center
    Springfield, Illinois 62781-0001
    Head and Neck Cancer
    S0508: Thalidomide and Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery
    Regional Cancer Center at Memorial Medical Center
    Springfield, Illinois 62781-0001
    Melanoma (Skin)
    Study Evaluating Biomarkers In Relapsed/Refractory Pediatric Solid Tumors
    Pfizer Investigational Site
    Springfield, Illinois 62701-1014
    Adenocarcinoma, Neoplasms
    S0430 Cyclophosphamide and Capecitabine in Treating Women With Stage IV Breast Cancer
    Regional Cancer Center at Memorial Medical Center
    Springfield, Illinois 62781-0001
    Breast Cancer
    S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
    Regional Cancer Center at Memorial Medical Center
    Springfield, Illinois 62781-0001
    Esophageal Cancer
    St. John's Wort in Relieving Hot Flashes in Postmenopausal Women With Non-Metastatic Breast Cancer
    CCOP - Central Illinois
    Springfield, Illinois 62526
    Breast Cancer, Hot Flashes
    A Study Of SU011248 As Therapy In Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer
    Pfizer Investigational Site
    Springfield, Illinois 62701-1014
    Non-small Cell Lung Cancer
    Study Evaluating Temsirolimus (CCI-779) In Mantle Cell Lymphoma (MCL)
    Pfizer Investigational Site
    Springfield, Illinois 62701-1014
    Lymphoma
    S0515 Combination Chemo, Rituximab, and Bevacizumab in Older Patients With Stage II-IV Diffuse Large B-Cell Lymphoma
    Regional Cancer Center at Memorial Medical Center
    Springfield, Illinois 62781-0001
    Lymphoma
    S0417 Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
    Regional Cancer Center at Memorial Medical Center
    Springfield, Illinois 62781-0001
    Multiple Myeloma
    Study of Intra-articular Delivery of tgAAC94 in Inflammatory Arthritis Subjects
    The Arthritis Center
    Springfield, Illinois 62704
    Arthritis, Rheumatoid, Arthritis, Psoriatic, Ankylosing Spondylitis
    Treatment Use Study With Sunitinib (SU011248) For Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma
    Pfizer Investigational Site
    Springfield, Illinois 62701-1014
    Carcinoma, Renal Cell
    Study Of SU011248 In Combination With Docetaxel (Taxotere) And Prednisone In Patients With Prostate Cancer
    Pfizer Investigational Site
    Springfield, Illinois 62701-1014
    Prostatic Neoplasms
    Pharmacogenomics Blood Sampling Protocol For Irinotecan/Fluorouracil/Leucovorin(CPT-11/FU/LV).
    Pfizer Investigational Site
    Springfield, Illinois 62701-1014
    Colorectal Neoplasms
    Adjuvant Epirubicin/Cytoxan Followed By A Taxane VS. Epirubicin/Taxane As Treatment For Node-Positive Breast Cancer
    Pfizer Investigational Site
    Springfield, Illinois 62701-1014
    Adenocarcinoma
    Prevention of Colorectal Sporadic Adenomatous Polyps (PRESAP)
    Pfizer Investigational Site
    Springfield, Illinois 62701-1014
    Colorectal Adenoma
    Postmenopausal Evaluation and Risk-reduction With Lasofoxifene (PEARL)
    Pfizer Investigational Site
    Springfield, Illinois 62701-1014
    Osteoporosis
    PH 1 Evaluation Of Oral CI-1033 In Combination With Paclitaxel/ Carboplatin As 1st Line Chemotherapy In NSCLC Patients
    Pfizer Investigational Site
    Springfield, Illinois 62701-1014
    Carcinoma, Non-Small Cell Lung
    Study Of SU011248 In Combination With Paclitaxel In Patients With Metastatic Breast Cancer
    Pfizer Investigational Site
    Springfield, Illinois 62701-1014
    Breast Neoplasms
    Study Evaluating Bazedoxifene Acetate In Osteoporosis In Postmenopausal Women
    Pfizer Investigational Site
    Springfield, Illinois 62701-1014
    Osteoporosis
    S0505 Sorafenib in Treating Patients With Advanced Soft Tissue Sarcomas
    Regional Cancer Center at Memorial Medical Center
    Springfield, Illinois 62781-0001
    Sarcoma
    S0511, Goserelin and Anastrozole in Treating Men With Recurrent or Metastatic Breast Cancer
    Regional Cancer Center at Memorial Medical Center
    Springfield, Illinois 62781-0001
    Breast Cancer
    S0509: AZD2171 in Treating Patients With Malignant Pleural Mesothelioma That Cannot Be Removed By Surgery
    Regional Cancer Center at Memorial Medical Center
    Springfield, Illinois 62781-0001
    Malignant Mesothelioma
    Open Label Study Of SU011248 In Combination With Trastuzumab For Patients With Metastatic Breast Cancer
    Pfizer Investigational Site
    Springfield, Illinois 62701-1014
    Breast Neoplasms
    Effectiveness of Rituximab in Pediatric OMS Patients.
    National Pediatric Myoclonus Center, Department of Neurology, SIU School of Medicine, 751 N Rutledge St
    Springfield, Illinois 62794
    Opsoclonus-myoclonus Syndrome, Opsoclonus, Myoclonus, Ataxia
    Study Of SU011248 Versus Chemotherapy For Patients With Previously Treated Triple Receptor Negative Breast Cancer
    Pfizer Investigational Site
    Springfield, Illinois 62701-1014
    Breast Neoplasms
    Trial of Paclitaxel/Carboplatin + PF-3512676 vs Paclitaxel/Carboplatin Alone in Patients With Advanced Non-Small Cell Lung Cancer
    Pfizer Investigational Site
    Springfield, Illinois 62701-1014
    Carcinoma, Non-Small-Cell Lung
    A Study In Patients With Non-Small Cell Lung Cancer Testing If Erlotinib Plus SU011248 (Sunitinib) Is Better Than Erlotinib Alone
    Pfizer Investigational Site
    Springfield, Illinois 62701-1014
    Carcinoma, Non-Small-Cell Lung
    Study Evaluating the Safety Of HKI-272 (Neratinib) In Subjects With Advanced Non-Small Cell Lung Cancer
    Pfizer Investigational Site
    Springfield, Illinois 62701-1014
    Carcinoma, Non-Small-Cell Lung, Lung Neoplasms